Ask AI

HER2-Directed ADCs in Bladder Cancer: Strategies to Personalize Treatment Selection and Optimize Patient Outcomes

Improve your ability to formulate individualized care strategies that incorporate ADCs for patients with HER2-expressing bladder cancer based on recent clinical evidence and expert recommendations through a certified on-demand webcast, ClinicalThought commentary, and downloadable slides.

Share

Program Content

Activities

HER2 ADCs in Bladder Cancer
HER2-Directed ADCs in Bladder Cancer: Strategies to Personalize Treatment Selection and Optimize Patient Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 02, 2025

Activities

HER2 ADCs in Bladder Cancer
HER2-Directed ADCs in Bladder Cancer: Strategies to Personalize Treatment Selection and Optimize Patient Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2025

Expires: June 16, 2026

Activities

HER2 ADCs in HER2 Pos Adv Bladder Cancer
Experts Answer Questions on HER2-Targeted ADCs in HER2-Positive Advanced Bladder Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Follicular Lymphoma Foundation

ProCE Banner